Clinical Study for Assessment of the Efficacy of Gabapentin (Carbatin and Neurontin) in Patients With Neuropathy Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

September 30, 2011

Conditions
NeuropathyPain
Interventions
DRUG

Carbatin

"Carbatin® or Neurontin® is initiated at 100 mg at night and slowly titrated to 300\~800 mg three times/day over 4 to 25 days.~The dose of Carbatin® or Neurontin® taken by each patient will amount to 100 to 2400 mg /day oral if the pain intensity reaches a VAS score ≧4. The maintenance dose of Carbatin® or Neurontin® will throughout for at least 14 days of the treatment period."

DRUG

Neurontin

"Carbatin® or Neurontin® is initiated at 100 mg at night and slowly titrated to 300\~800 mg three times/day over 4 to 25 days.~The dose of Carbatin® or Neurontin® taken by each patient will amount to 100 to 2400 mg /day oral if the pain intensity reaches a VAS score ≧4. The maintenance dose of Carbatin® or Neurontin® will throughout for at least 14 days of the treatment period."

Trial Locations (1)

712

Nang Kuang Pharmaceutical Co., LTD, Tainan City

All Listed Sponsors
collaborator

Taichung Veterans General Hospital

OTHER

lead

Nang Kuang Pharmaceutical Co., Ltd.

INDUSTRY